Context:
For reliable antibody testing kits, India will have to make its own, according to independent epidemiologists and biotechnologists.
A day after the Rajasthan government said that it would stop antibody tests because they were returning inaccurate results, the Indian Council of Medical Research announced that it had advised putting such tests on hold because it was generating widely varying results.
The ICMR on Wednesday said it had forwarded a “protocol” for rapid
Janaushadhi Sugam Mobile
Context:
Over 325000 people are using “Janaushadhi Sugam” Mobile App to access Janaushadhi kendras.
Amid nationwide lockdown due to COVID-19 crisis Janaushadhi Sugam Mobile App is helping people in a big way to locate their nearest Pradhan Mantri Bharatiya Janaushadhi Kendra (PMJAK) and availability of affordable generic medicine with its price.
Over 325000 people are using Janaushadhi Sugam Mobile App to avail the host of benefits provide
Context:
Technologists at the Sree Chitra Triunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute under the Department of Science and Technology, Govt of India, have developed two types of nasal and oral swabs and viral transport medium for COVID-19 testing.
2 types of nasal and oral swabs
Chitra EmBed flocked nylon swabs
Chitra EnMesh, polymeric foam-tipped, lint-free swabs with flexible plastic handles
They have good recovery of viral RNA c
NIAB develops portable coronavirus detection kit
Introduction
National Institute of Animal Biotechnology (NIAB), Hyderabad, have developed a biosensor that can detect the novel coronavirus in saliva samples.
Biosensors have been currently used across the world to detect toxins, narcotic drugs, and are also considered as a reliable tool to detect infectious diseases.
eCovSens
The new portable device named eCovSens, can be used to detect the presence of novel coronavirus antigens i
When will a COVID-19 vaccine be ready?
Oxford University starts its human clinical trials of its vaccine
Oxford University initiated a phase-1 human clinical trial of its vaccine — ChAdOx1 nCoV-19 — against the novel coronavirus, SARS-CoV-2. A single dose of the candidate vaccine will be administered to 1,112 healthy volunteers to study the safety, ability to produce immune response and efficacy of the vaccine.
Oxford University is optimistic of a positive outcome of the ca
Indian Navy’s Personal Protective Equipment (PPE)
Personal Protective Equipment (PPE) designed and produced by Indian Navy has been tested by INMAS (Institute of Nuclear Medicine and Allied Sciences) Delhi, a DRDO organization tasked with the testing and certification of PPE and is certified to be mass produced and used in clinical COVID situations.
Shortage of Personal Protective Equipment (PPE) during the ongoing COVID-19 pandemic is of serious concern as it imperils the well-being